Luciano F Drager1,2, Daniela V Pachito3,4, Claudia R C Moreno5,6, Almir R Tavares7, Silvia G Conway8,9, Márcia Assis10, Danilo A Sguillar11, Gustavo A Moreira12, Andrea Bacelar13, Pedro R Genta14. 1. Unidade de Hipertensão, Departamento de Clinica Medica, Disciplina de Nefrologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil. 2. Unidade de Hipertensão, Instituto do Coração (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil. 3. Núcleo de Avaliação de Tecnologias em Saúde, Hospital Sírio-Libanês, São Paulo, Brazil. 4. Fundação Getúlio Vargas, São Paulo, Brazil. 5. School of Public Health, University of São Paulo, São Paulo, Brazil. 6. Stress Research Institute, Department of Psychology, Stockholm University, Stockholm, Sweden. 7. Neurosciences Postgraduate Program, Federal University of Minas Gerais, Belo Horizonte, Brazil. 8. Akasa-Formação e Conhecimento, São Paulo, Brazil. 9. Psychiatry Department, University of São Paulo Medical School, São Paulo, Brazil. 10. Clínica do Sono de Curitiba, Hospital São Lucas, Curitiba Paraná, Brazil. 11. ENT Department of Universidade Federal de Sao Paulo, São Paulo, Brazil. 12. Department of Pediatrics and Psychobiology, Universidade Federal de Sao Paulo, São Paulo, Brazil. 13. Carlos Bacelar Clinica, Rio de Janeiro, Brazil. 14. Laboratório do Sono, LIM 63, Pulmonary Division, Heart Institute (InCor), Hospital das Clínicas HCFMUSP, Universidade de São Paulo, São Paulo, Brazil.
Abstract
STUDY OBJECTIVES: To evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on insomnia and other sleep disturbances in health care professionals. METHODS: A survey was distributed using social media and organizational emails to Brazilian active health care professionals during the COVID-19 outbreak. We explored potential associated factors including age, sex, occupation, workplace, work hours, income, previous infection with COVID-19, recent/current contact with COVID-19 patients, regional number of incident deaths, anxiety, and burnout. We evaluated new-onset/previous insomnia worsening episodes (primary outcome), new pharmacological treatments, sleep quality, duration, nightmares, and snoring (secondary outcomes). RESULTS: A total of 4,384 health professionals from all regions of the country were included in the analysis (44 ± 12 years, 76% females, 53.8% physicians). Overall, 55.7% were assisting patients with COVID-19, and 9.2% had a previous COVID-19 infection. The primary outcome occurred in 32.9% of respondents in parallel to 13% new pharmacological treatments for insomnia. The sleep quality worsened for 61.4%, while 43.5% and 22.8% reported ≥ 1-hour sleep duration reduction and worsening or new-onset nightmares, respectively. Multivariate analyses showed that age (odds ratio [OR]: 1.008; 95% confidence interval [CI] 1.001-1.015), females (OR: 1.590; 95% CI 1.335-1.900), weight change (decrease: OR: 1.772; 95% CI 1.453-2.161; increase: OR: 1.468; 95% CI 1.249-1.728), prevalent anxiety (OR: 3.414; 95% CI 2.954-3.948), new-onset burnout (OR: 1.761; 95% CI 1.489-2.083), family income reduction > 30% (OR: 1.288; 95% CI 1.069-1.553), and assisting patients with COVID-19 (OR: 1.275; 95% CI 1.081-1.506) were independently associated with new-onset or worsening of previous insomnia episodes. CONCLUSIONS: We observed a huge burden of insomnia episodes and other sleep disturbances in health care professionals during the COVID-19 pandemic. CITATION: Drager LF, Pachito DV, Moreno CRC, et al. Insomnia episodes, new-onset pharmacological treatments, and other sleep disturbances during the COVID-19 pandemic: a nationwide cross-sectional study in Brazilian health care professionals. J Clin Sleep Med. 2022;18(2):373-382.
STUDY OBJECTIVES: To evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on insomnia and other sleep disturbances in health care professionals. METHODS: A survey was distributed using social media and organizational emails to Brazilian active health care professionals during the COVID-19 outbreak. We explored potential associated factors including age, sex, occupation, workplace, work hours, income, previous infection with COVID-19, recent/current contact with COVID-19 patients, regional number of incident deaths, anxiety, and burnout. We evaluated new-onset/previous insomnia worsening episodes (primary outcome), new pharmacological treatments, sleep quality, duration, nightmares, and snoring (secondary outcomes). RESULTS: A total of 4,384 health professionals from all regions of the country were included in the analysis (44 ± 12 years, 76% females, 53.8% physicians). Overall, 55.7% were assisting patients with COVID-19, and 9.2% had a previous COVID-19 infection. The primary outcome occurred in 32.9% of respondents in parallel to 13% new pharmacological treatments for insomnia. The sleep quality worsened for 61.4%, while 43.5% and 22.8% reported ≥ 1-hour sleep duration reduction and worsening or new-onset nightmares, respectively. Multivariate analyses showed that age (odds ratio [OR]: 1.008; 95% confidence interval [CI] 1.001-1.015), females (OR: 1.590; 95% CI 1.335-1.900), weight change (decrease: OR: 1.772; 95% CI 1.453-2.161; increase: OR: 1.468; 95% CI 1.249-1.728), prevalent anxiety (OR: 3.414; 95% CI 2.954-3.948), new-onset burnout (OR: 1.761; 95% CI 1.489-2.083), family income reduction > 30% (OR: 1.288; 95% CI 1.069-1.553), and assisting patients with COVID-19 (OR: 1.275; 95% CI 1.081-1.506) were independently associated with new-onset or worsening of previous insomnia episodes. CONCLUSIONS: We observed a huge burden of insomnia episodes and other sleep disturbances in health care professionals during the COVID-19 pandemic. CITATION: Drager LF, Pachito DV, Moreno CRC, et al. Insomnia episodes, new-onset pharmacological treatments, and other sleep disturbances during the COVID-19 pandemic: a nationwide cross-sectional study in Brazilian health care professionals. J Clin Sleep Med. 2022;18(2):373-382.
Authors: Alyssa M Civantos; Yasmeen Byrnes; Changgee Chang; Aman Prasad; Kevin Chorath; Seerat K Poonia; Carolyn M Jenks; Andrés M Bur; Punam Thakkar; Evan M Graboyes; Rahul Seth; Samuel Trosman; Anni Wong; Benjamin M Laitman; Brianna N Harris; Janki Shah; Vanessa Stubbs; Garret Choby; Qi Long; Christopher H Rassekh; Erica Thaler; Karthik Rajasekaran Journal: Head Neck Date: 2020-06-04 Impact factor: 3.147
Authors: Luca A Morgantini; Ushasi Naha; Heng Wang; Simone Francavilla; Ömer Acar; Jose M Flores; Simone Crivellaro; Daniel Moreira; Michael Abern; Martin Eklund; Hari T Vigneswaran; Stevan M Weine Journal: PLoS One Date: 2020-09-03 Impact factor: 3.240
Authors: W El-Hage; C Hingray; C Lemogne; A Yrondi; P Brunault; T Bienvenu; B Etain; C Paquet; B Gohier; D Bennabi; P Birmes; A Sauvaget; E Fakra; N Prieto; S Bulteau; P Vidailhet; V Camus; M Leboyer; M-O Krebs; B Aouizerate Journal: Encephale Date: 2020-04-22 Impact factor: 1.291
Authors: Claudia Roberta de Castro Moreno; Silvia G Conway; Márcia Assis; Pedro Rodrigues Genta; Daniela V Pachito; Almir Tavares; Danilo A Sguillar; Gustavo Moreira; Luciano F Drager; Andrea Bacelar Journal: Sleep Sci Date: 2022 Jan-Mar
Authors: Hailey Meaklim; Malisa Burge; Flora Le; Sukjhit K Bains; William Saunders; Stephen Ghosh; Moira F Junge; Prerna Varma; Imogen C Rehm; Melinda L Jackson Journal: J Sleep Res Date: 2022-06-14 Impact factor: 5.296